Mediolanum International Funds Limited (MIFL) an Irish asset management company approved by the Central Bank of Ireland to manage UCITS & Non UCITS Funds. It is the research and development (R&D) and funds product innovation centre (MedLab®) for the Mediolanum Banking Group managing 65 funds with over €70.8 billion in assets under management as of December 2024.

MIFL focuses on the needs of investors, aiming for the highest quality standards for investment services and is the largest asset manager in EMEA for sub-advisory mandates within the banking distribution channel1

MIFL funds are available to all 1.9 million clients of the Mediolanum Group, based on their eligibility requirements, and are supported by over 6,400 Family Bankers® in Italy and Spain and multiple pools of Independent Financial Advisors in Germany, as well as numerous institutional investors.

Research and development

MIFL undertakes significant proprietary R&D and collaborates with selected international partners, leveraging its open innovation platform and proprietary process (MedInSynC®), with a view to developing in-house solutions tailored to meet clients’ needs.

This ensures we can deliver value-adding investment products and services to our predominantly European retail client base. MIFL is also one of the pioneers for the protection of intellectual property in the funds industry and is very active in shaping evolving market best practice in this area.